{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:41:17Z","timestamp":1791859277003,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["721815"],"award-info":[{"award-number":["721815"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93020D00005"],"award-info":[{"award-number":["75N93020D00005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20-GM113132"],"award-info":[{"award-number":["P20-GM113132"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015400","name":"Fonds Erasme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.xcrm.2022.100818","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:02:24Z","timestamp":1668556944000},"page":"100818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation"],"prefix":"10.1016","volume":"3","author":[{"given":"Pranay","family":"Bharadwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Pongracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalano","family":"Concetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpee","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Le Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo V.","family":"Riella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Holovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-3476","authenticated-orcid":false,"given":"Margaret E.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100818_bib1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/jcm9041193","article-title":"Recent advances and clinical outcomes of kidney transplantation","volume":"9","author":"Thongprayoon","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.xcrm.2022.100818_bib2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/ajt.15323","article-title":"Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection","volume":"19","author":"Chong","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/TP.0000000000001391","article-title":"Prevalence and clinical impact of donor-specific alloantibody among intestinal transplant recipients","volume":"101","author":"Cheng","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trre.2016.10.004","article-title":"Acute antibody-mediated rejection in kidney transplant recipients","volume":"31","author":"Davis","year":"2017","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.xcrm.2022.100818_bib5","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1172\/JCI90597","article-title":"Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies","volume":"127","author":"Valenzuela","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100818_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21st century","volume":"6","author":"Black","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.xcrm.2022.100818_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.07720715","article-title":"Allocating deceased donor kidneys to candidates with high panel-reactive antibodies","volume":"11","author":"Gebel","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2022.100818_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-6143.2009.02927.x","article-title":"Calculated PRA (CPRA): the new measure of sensitization for transplant candidates: sensitized patients, PRA and CPRA","volume":"10","author":"Cecka","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss","volume":"28","author":"Viglietti","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2022.100818_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: a prospective trial: prediction of failure by antibodies","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cll.2018.10.007","article-title":"Donor-specific HLA antibodies as biomarkers of transplant rejection","volume":"39","author":"Timofeeva","year":"2018","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.xcrm.2022.100818_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.humimm.2015.07.224","article-title":"Characteristics of donor-specific anti-HLA antibodies in renal transplant recipients","volume":"76","author":"Ghandorah","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ctr.12529","article-title":"Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation","volume":"29","author":"Visentin","year":"2015","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/tri.13436","article-title":"The therapeutic challenge of late antibody-mediated kidney allograft rejection","volume":"32","author":"B\u00f6hmig","year":"2019","journal-title":"Transpl. Int."},{"key":"10.1016\/j.xcrm.2022.100818_bib15","article-title":"Acute antibody-mediated rejection in kidney transplantation: clinical and therapeutic aspects","volume":"4","author":"Salvadori","year":"2013","journal-title":"J.\u00a0Nephrol. Ther."},{"key":"10.1016\/j.xcrm.2022.100818_bib16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/ajt.12150","article-title":"Molecular diagnosis of antibody-mediated rejection in human kidney transplants","volume":"13","author":"Sellar\u00e9s","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2022.100818_bib18","first-page":"7903471","article-title":"Not all antibodies are created equal: factors that influence antibody mediated rejection","volume":"2017","author":"Butler","year":"2017","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.xcrm.2022.100818_bib19","first-page":"5986740","article-title":"Kidney transplantation: the challenge of human leukocyte antigen and its therapeutic strategies","volume":"2018","author":"Alelign","year":"2018","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.xcrm.2022.100818_bib20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/ajt.14721","article-title":"De novo donor-specific antibodies in belatacept-treated vs. Cyclosporine-treated kidney transplant recipients: post-hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies","volume":"18","author":"Bray","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib21","doi-asserted-by":"crossref","first-page":"S484","DOI":"10.1097\/01.tp.0000543294.46098.2d","article-title":"Clinical importance of non-donor-specific HLA antibodies and possible impact on graft histology in kidney transplant recipients\u00a0\u2013 12 Months protocol biopsy study","volume":"102","author":"Severova","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney","volume":"20","author":"Hart","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ajt.15873","article-title":"Experimental modeling of desensitization: what have we learned about preventing AMR?","volume":"20","author":"Kwun","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib25","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1097\/TP.0000000000002903","article-title":"Immunosuppression and reproductive health after kidney transplantation","volume":"103","author":"Chandra","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/tan.13664","article-title":"Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: excellent tools to study differential effects of donor-specific antibodies","volume":"94","author":"Kramer","year":"2019","journal-title":"Hla"},{"key":"10.1016\/j.xcrm.2022.100818_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2022.100818_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fimmu.2016.00433","article-title":"Antibody subclass repertoire and graft outcome following solid organ transplantation","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/ajt.13153","article-title":"Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation","volume":"15","author":"O'Leary","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.TP.0000441362.11232.48","article-title":"Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients","volume":"97","author":"Everly","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib32","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jim.2005.08.009","article-title":"IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides","volume":"306","author":"Niwa","year":"2005","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2022.100818_bib34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/bit.20777","article-title":"Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II","volume":"93","author":"Ferrara","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.xcrm.2022.100818_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib36","doi-asserted-by":"crossref","first-page":"eaat7796","DOI":"10.1126\/sciimmunol.aat7796","article-title":"Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement","volume":"3","author":"Lofano","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100818_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/infdis\/jiz364","article-title":"Survivors of Ebola virus disease develop polyfunctional antibody responses","volume":"221","author":"Gunn","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2022.100818_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib40","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1038\/s41598-017-12495-0","article-title":"Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health","volume":"7","author":"Plomp","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2022.100818_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100818_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.aids.0000161767.21405.68","article-title":"Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals","volume":"19","author":"Moore","year":"2005","journal-title":"Aids"},{"key":"10.1016\/j.xcrm.2022.100818_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1089\/088922200309007","article-title":"IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects","volume":"16","author":"Raux","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.xcrm.2022.100818_bib44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-Fc fucosylation of platelet\u00a0alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2022.100818_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood-2012-11-468561","article-title":"Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti\u2013HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia","volume":"122","author":"Bakchoul","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2022.100818_bib46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib47","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2022.100818_bib48","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies","volume":"9","author":"Loupy","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib49","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/tri.12648","article-title":"Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure","volume":"28","author":"Khovanova","year":"2015","journal-title":"Transpl. Int."},{"key":"10.1016\/j.xcrm.2022.100818_bib50","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3389\/fimmu.2019.02380","article-title":"The role of complement in organ transplantation","volume":"10","author":"Grafals","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib51","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3389\/fimmu.2019.01712","article-title":"Characterization of the C1q-binding ability and the IgG1-4 subclass profile of preformed anti-HLA antibodies by solid-phase assays","volume":"10","author":"Navas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.molimm.2019.06.002","article-title":"The role of complement in antibody mediated transplant rejection","volume":"112","author":"Thurman","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib53","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41581-018-0071-x","article-title":"The multifaceted role of complement in kidney transplantation","volume":"14","author":"Biglarnia","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.xcrm.2022.100818_bib54","doi-asserted-by":"crossref","first-page":"e0207434","DOI":"10.1371\/journal.pone.0207434","article-title":"Clinical impact of complement (C1q, C3d) binding de novo donor-specific HLA antibody in kidney transplant recipients","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2022.100818_bib55","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2022.100818_bib56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement-binding de novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2022.100818_bib57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/tri.12873","article-title":"Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation","volume":"30","author":"Malheiro","year":"2017","journal-title":"Transpl. Int."},{"key":"10.1016\/j.xcrm.2022.100818_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.trim.2019.02.005","article-title":"Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection","volume":"54","author":"Sablik","year":"2019","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib59","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/TP.0000000000001586","article-title":"Evidence for CD16a-mediated NK cell stimulation in antibody-mediated kidney transplant rejection","volume":"101","author":"Parkes","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.kint.2018.08.027","article-title":"Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation","volume":"95","author":"Yazdani","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.xcrm.2022.100818_bib61","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection","author":"Lamarth\u00e9e","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.xcrm.2022.100818_bib62","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody: post- dn DSA clinical histologic progression","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib63","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant: clinical pathologic correlations of de novo DSA","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2022.100818_bib64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ekir.2019.02.011","article-title":"Transplant glomerulopathy with glomerular C3 deposits: why the worse outcome?","volume":"4","author":"Yamashita","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.xcrm.2022.100818_bib65","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fimmu.2017.01310","article-title":"Impact of preformed donor-specific anti-human leukocyte antigen antibody C1q-binding ability on kidney allograft outcome","volume":"8","author":"Molina","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib66","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/01.TP.0000442503.85766.91","article-title":"Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies","volume":"97","author":"Gupta","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib67","first-page":"367","article-title":"Post-transplant development of C1q-positive HLA antibodies and kidney graft survival","author":"Piazza","year":"2013","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.xcrm.2022.100818_bib68","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1172\/JCI130029","article-title":"Functional diversification of IgGs through Fc glycosylation","volume":"129","author":"Wang","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100818_bib69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2016.03.002","article-title":"Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies","volume":"73","author":"Thomann","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/ph3010146","article-title":"Impact of glycosylation on effector functions of therapeutic IgG","volume":"3","author":"Ab\u00e8s","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.xcrm.2022.100818_bib71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.coi.2008.06.007","article-title":"Terminal sugars of Fc glycans influence antibody effector functions of IgGs","volume":"20","author":"Raju","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib72","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N -acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2022.100818_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.humimm.2017.06.281","article-title":"P221 \u201cNaturally occuring\u201d anti-HLA antibodies","volume":"78","author":"Elkhalifa","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib74","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/TP.0b013e318186d87b","article-title":"\u201cNatural\u201d human leukocyte antigen antibodies found in nonalloimmunized healthy males","volume":"86","author":"Morales-Buenrostro","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2022.100818_bib75","doi-asserted-by":"crossref","first-page":"618685","DOI":"10.3389\/fimmu.2020.618685","article-title":"Distinct features and functions of systemic and mucosal humoral immunity among SARS-CoV-2 convalescent individuals","volume":"11","author":"Butler","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2022.100818_bib77","doi-asserted-by":"crossref","first-page":"e0049","DOI":"10.5041\/RMMJ.10049","article-title":"Challenges in organ transplantation","volume":"2","author":"Beyar","year":"2011","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.xcrm.2022.100818_bib78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.xcrm.2022.100818_bib79","first-page":"6804678","article-title":"Desensitization: overcoming the immunologic barriers to transplantation","volume":"2017","author":"Sethi","year":"2017","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.xcrm.2022.100818_bib80","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fimmu.2016.00570","article-title":"Detection of HLA antibodies in organ transplant recipients\u00a0\u2013 triumphs and challenges of the solid phase bead assay","volume":"7","author":"Tait","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.humimm.2008.06.013","article-title":"Detecting and monitoring human leukocyte antigen\u2013specific antibodies","volume":"69","author":"Zachary","year":"2008","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib82","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.humimm.2015.10.021","article-title":"Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection","volume":"77","author":"Malard-Castagnet","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/tri.12206","article-title":"Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1\/IgG3 to noncomplement fixing IgG2\/IgG4 anti-HLA alloantibodies","volume":"27","author":"Arnold","year":"2014","journal-title":"Transpl. Int."},{"key":"10.1016\/j.xcrm.2022.100818_bib84","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.it.2017.02.004","article-title":"The immunoregulatory roles of antibody glycosylation","volume":"38","author":"Jennewein","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib85","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1073\/pnas.1702173114","article-title":"Modulating IgG effector function by Fc glycan engineering","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2022.100818_bib86","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib87","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2022.100818_bib88","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.abc7303","article-title":"Antibody fucosylation predicts disease severity in secondary dengue infection","volume":"372","author":"Bournazos","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100818_bib89","doi-asserted-by":"crossref","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100818_bib90","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib91","doi-asserted-by":"crossref","first-page":"103957","DOI":"10.1016\/j.ebiom.2022.103957","article-title":"Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19","volume":"78","author":"Pongracz","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2022.100818_bib92","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41590-020-00828-7","article-title":"Proinflammatory IgG Fc structures in patients with severe COVID-19","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib93","doi-asserted-by":"crossref","first-page":"eabm7853","DOI":"10.1126\/scitranslmed.abm7853","article-title":"Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2022.100818_bib94","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection","author":"Lamarth\u00e9e","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.xcrm.2022.100818_bib95","doi-asserted-by":"crossref","first-page":"eabf8654","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2022.100818_bib96","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.12965","article-title":"Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn","volume":"166","author":"Kapur","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2022.100818_bib97","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2022.100818_bib98","doi-asserted-by":"crossref","first-page":"1893427","DOI":"10.1080\/19420862.2021.1893427","article-title":"Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation","volume":"13","author":"Wei","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2022.100818_bib99","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/imr.12503","article-title":"Systems serology for evaluation of HIV vaccine trials","volume":"275","author":"Ackerman","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.xcrm.2022.100818_bib100","doi-asserted-by":"crossref","first-page":"e7881","DOI":"10.15252\/msb.20177881","article-title":"High-resolution definition of humoral immune response correlates of effective immunity against HIV","volume":"14","author":"Alter","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.xcrm.2022.100818_bib101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coi.2020.06.003","article-title":"Dissecting the antibody-OME: past, present, and future","volume":"65","author":"Loos","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib102","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","article-title":"Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy","volume":"162","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2022.100818_bib103","doi-asserted-by":"crossref","first-page":"104101","DOI":"10.1016\/j.ebiom.2022.104101","article-title":"IgG N-glycome changes during the course of severe COVID-19: an observational study","volume":"81","author":"Petrovi\u0107","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2022.100818_bib104","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4161\/mabs.28808","article-title":"Highly parallel characterization of IgG Fc binding interactions","volume":"6","author":"Boesch","year":"2014","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2022.100818_bib105","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.jproteome.6b00171","article-title":"LaCyTools: a targeted liquid chromatography\u2013mass spectrometry data processing package for relative quantitation of glycopeptides","volume":"15","author":"Jansen","year":"2016","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.xcrm.2022.100818_bib106","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molimm.2017.08.014","article-title":"Identification and verification of hybridoma-derived monoclonal antibody variable region sequences using recombinant DNA technology and mass spectrometry","volume":"90","author":"Babrak","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib107","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2020.00740","article-title":"Fc\u03b3R binding and ADCC activity of human IgG allotypes","volume":"11","author":"de Taeye","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib108","doi-asserted-by":"crossref","first-page":"36964","DOI":"10.1038\/srep36964","article-title":"Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans","volume":"6","author":"Dekkers","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2022.100818_bib109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jim.2015.06.005","article-title":"Microscale purification of antigen-specific antibodies","volume":"425","author":"Brown","year":"2015","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2022.100818_bib110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2012.09.007","article-title":"High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples","volume":"386","author":"Brown","year":"2012","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2022.100818_bib111","article-title":"Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses","author":"Crowley","year":"2022","journal-title":"Immunogenetics"},{"key":"10.1016\/j.xcrm.2022.100818_bib112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-6493-2_4","article-title":"High-throughput analysis of IgG Fc glycopeptides by LC-MS","volume":"1503","author":"Falck","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2022.100818_bib113","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fimmu.2017.00608","article-title":"The N-glycosylation of mouse immunoglobulin G (IgG)-Fragment crystallizable differs between IgG subclasses and strains","volume":"8","author":"de Haan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2022.100818_bib114","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","article-title":"Human plasma protein N-glycosylation","volume":"33","author":"Clerc","year":"2016","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.xcrm.2022.100818_bib115","doi-asserted-by":"crossref","first-page":"107642","DOI":"10.1016\/j.celrep.2020.107642","article-title":"Maternal anti-dengue IgG fucosylation predicts susceptibility to dengue disease in infants","volume":"31","author":"Thulin","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2022.100818_bib116","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jim.2018.11.002","article-title":"Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region","volume":"464","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2019","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2022.100818_bib117","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.4049\/jimmunol.1103495","article-title":"An NKp30-based chimeric antigen receptor promotes T\u00a0cell effector functions and antitumor efficacy in\u00a0vivo","volume":"189","author":"Zhang","year":"2012","journal-title":"J.\u00a0Immunol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122003779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122003779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:54:16Z","timestamp":1762988056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122003779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":117,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2666379122003779"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100818","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.09.22272152","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Afucosylation of HLA-specific IgG1 as a potential predictor of antibody pathogenicity in kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100818"}}